Research advances of autoimmune liver diseases in 2018
10.3760/cma.j.issn.1007-3418.2019.01.005
- VernacularTitle: 自身免疫性肝病2018年研究进展
- Author:
Yong CHEN
1
;
Qixia WANG
;
Xiong MA
Author Information
1. Department of Gastroenterology, Renji Hospital, Shanghai Jiaotong University School of Medicine;Institute of Digestive Disease, Shanghai 200001, China
- Publication Type:Journal Article
- Keywords:
Hepatitis, autoimmune;
Primary biliary cholangitis;
Primary sclerosing cholangitis
- From:
Chinese Journal of Hepatology
2019;27(1):14-17
- CountryChina
- Language:Chinese
-
Abstract:
Autoimmune liver disease is a group of hepatobiliary injuries mediated by abnormal immunity. It mainly includes autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. Recently, an advancement of diagnostic technology has improved the detection and treatment of autoimmune hepatitis. However, it is easy to be confused with other liver diseases. Thus, the standardization of diagnosis and treatment of autoimmune liver diseases has become a main concern. Moreover, new progress has been made in basic research and clinical treatment of autoimmune liver diseases since 2018. In this review, we have introduced the latest research advances for the diagnosis and treatment of autoimmune liver diseases.
